X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cipla Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla Quarterly Results   (CIPL)

Here are the latest quarterly results of Cipla. For more details, see the Cipla financial fact sheet and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Cipla Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m38,52834,52431,06632,66535,93737,51036,47235,820 
Other income Rs m4892597935472522721,535228 
Turnover Rs m39,01734,78331,85933,21336,18937,78338,00736,048 
Expenses Rs m28,13826,63026,52830,47629,82830,70329,69630,758 
Gross profit Rs m10,3217,7084,3632,0046,0306,6346,6675,053 
Depreciation Rs m1,2881,3401,3751,4141,6082,2922,5776,322 
Interest Rs m514503230367313352593334 
Profit before tax Rs m9,0096,1253,5527704,3614,2625,031-1,375 
Tax Rs m2,5031,812120-397087191,283-757 
Profit after tax Rs m6,5064,3123,4328093,6523,5433,748-618 
Gross profit margin %26.822.314.06.116.817.718.314.1 
Effective tax rate %27.829.63.4-5.116.216.925.555.1 
Net profit margin %16.912.511.02.510.29.410.3-1.7 
Diluted EPS Rs 8.1 5.4 4.3 1.0 4.5 4.4 4.7 -0.8  
Diluted EPS (TTM) Rs 19.1 20.8 20.9 18.7 15.2 14.2 14.6 12.8  
 Subscriber Feature View   View View View   View    
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   J.B.CHEMICALS  GSK PHARMA  ASTRAZENECA PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare CIPLA With:   J.B.CHEMICALS  GSK PHARMA  ASTRAZENECA PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare CIPLA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty Ends Above 10,000; Yes Bank Surges 6% on Strong Q1 Result(Closing)

Share markets in India ended the day higher with Nifty50 settling above the 10,000-mark for the first time. At the closing bell, the BSE Sensex closed higher by 154 points.

Views on news

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

More Views on News

Most Popular

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The Real Returns from Real Estate Have Been Very Low(Vivek Kaul's Diary)

Jul 17, 2017

Real estate prices across India have barely gone anywhere over the last four years. Prices have fallen in many cities over the last one-year, new data from the National Housing Bank suggests.

Trade the Markets like Roger Federer Plays Tennis(Daily Profit Hunter)

Jul 19, 2017

Trading is one of the most competitive fields in the world today. To win, you must adopt the mindset of a Grand Slam champion.

Sold Your Immoveable Property? Here Are The Tax Implications...(Outside View)

Jul 19, 2017

When you're selling an immoveable property, it becomes imperative to recognise the intricate tax implications.

Affordable Housing Gaining Traction(Chart Of The Day)

Jul 15, 2017

Affordable housing is gaining traction amid continuing slowdown in the property market.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Jul 26, 2017 (Close)

TRACK CIPLA

CIPLA - MYLAN COMPARISON

COMPARE CIPLA WITH

MARKET STATS